Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
PRA Group (PRAA): Assessing the +105% Path to the $26 Analyst Target

PRA Group (PRAA): Assessing the +105% Path to the $26 Analyst Target

Key Takeaways

  • The central target used here is $26.00, the widely reported average analyst price target for PRAA.
  • Coverage is thin: the clearest named, current target is Truist Financial's $26 Buy rating (August 2026), echoed across data providers as the consensus figure.
  • At the last verified close of $12.71 (November 9, 2026), reaching $26.00 would require a gain of roughly 105% — a very large move.
  • That target was set before the November 5 Q3 2026 earnings miss, which triggered a roughly 37% one-day decline, so its current relevance is uncertain.
  • The strongest supports are stable cash collections, rising adjusted EBITDA, and a deep discount to book value.
  • The biggest risks are the earnings miss, a heavy debt load, and the possibility that analysts revise targets lower.
  • For more context, visit the Major News and Today's Price Move pages, or review the Forecast and Earnings pages for this ticker.
  • Explore Trending AI Robots to see automated strategies monitoring stocks like PRAA.

Analyst Price Targets and Consensus View

The analyst picture for PRA Group is unusually narrow. Data providers generally report a consensus price target of $26.00, but the underlying coverage is thin — roughly three to five analysts, with only one clearly attributable current target: Truist Financial's $26 Buy rating issued in August 2026. The overall ratings mix is cautious, skewing toward Hold, with one Buy and one Sell alongside Hold ratings, according to data aggregators. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

A critical caveat: the $26.00 target predates the company's November 5, 2026 third-quarter results. Analysts had already been trimming expectations — the target was cut from $33 to $26 in late 2025 — and Citizens JMP downgraded the stock to Market Perform in January 2026. Because no verifiable analyst has republished a target since the Q3 miss, the $26.00 figure should be read as a consensus-in-flux rather than a firm, freshly reaffirmed forecast.

Current Market Position and Path Toward the Target

Shares of PRAA closed at $12.71 on November 9, 2026, after tumbling about 37% in a single session following third-quarter results. The 52-week range is $10.25 to $22.55. To reach $26.00, the stock would need to climb roughly 105% — a very large move that would require not only recovering the entire post-earnings loss but trading well above the prior 52-week high of $22.55.

The fundamental path is mixed. Third-quarter adjusted EPS of $0.39 fell well short of the roughly $0.80 FactSet consensus, and revenue of $286.3 million missed the approximately $307.4 million estimate. At the same time, cash collections were steady at $536 million, trailing 12-month adjusted EBITDA rose 9% to about $1.4 billion, and net leverage declined to 2.6x — an eighth consecutive quarter of deleveraging. The stock trades at a price-to-book ratio near 0.45 and a forward P/E around 5.6, reflecting deep investor skepticism.

What Could Support a Move Toward the Target

  • Stable collections and cost control: Cash collections exceeded internal expectations, and cost-cutting lifted adjusted cash efficiency by more than 200 basis points to 63%.
  • Deleveraging: Net leverage has fallen for eight straight quarters, supported by a $400 million senior notes issuance due 2033 at 8.5%.
  • Valuation: The stock trades at a steep discount to book value, which some analysts argue understates near-term earnings power.
  • Global capital flexibility: The company can shift portfolio purchasing toward Europe, where it reports more attractive supply and returns.

What Could Prevent the Target From Being Reached

  • Earnings execution: The Q3 miss on both EPS and revenue raises doubts about the trajectory that underpinned the $26 target.
  • Potential target cuts: Because the consensus figure predates the miss, analysts may lower it, narrowing the apparent upside.
  • Leverage and financing costs: With a debt-to-equity ratio above 3.0 and recent high-yield issuance, interest expense is a meaningful drag.
  • Regulatory and collection risk: Debt-collection operations face ongoing regulatory scrutiny and macroeconomic sensitivity in the U.S. and Europe.

Technical Levels and Market Structure

The stock is technically damaged after the post-earnings plunge. Immediate support sits near $11.96 (the recent session low) and the 52-week low of $10.25. On the upside, resistance appears near $15–$16, followed by the 200-day moving average around $17.53, the 50-day average near $19.65, and the 52-week high of $22.55. A durable move toward $26.00 would require clearing each of these zones — a task made harder by the size of the recent breakdown. From what I see, the recent breakdown stands out as particularly sharp.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though the exact horizon of the $26.00 figure is not clearly stated and may differ by firm. Investors should watch the next quarterly and full-year report, expected in late February or early March 2027, along with any analyst target revisions in the interim. Cash collections, adjusted EBITDA, net leverage, portfolio purchasing activity, and any guidance on the PRA 3.0 restructuring strategy are the most relevant metrics.

Final Assessment

The question of whether PRA Group can reach $26.00 hinges on a target that now looks disconnected from the post-earnings reality. The $26.00 figure represents a thin, largely single-source analyst view that predates a major Q3 miss, while the stock would need to more than double — a very large move — to get there. Support comes from stable collections, cost discipline, deleveraging, and a discounted valuation, but the earnings shortfall, heavy debt, and the risk of downward target revisions are formidable obstacles. The most important near-term signals will be analyst updates and the next earnings report. In my view, the disconnect between the target and current conditions is worth watching closely.

AI Daily Buy/Sell Signals

In my trading process, Tickeron’s AI Daily Buy/Sell Signals help monitor volatile names like PRAA by generating signals based on market conditions and technical behavior. The tool continuously scans thousands of stocks and ETFs, allowing me to spot momentum shifts more efficiently without tracking every chart manually. It fits well into a broader research routine for staying informed on opportunities and risks.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PRAA

PRAA's Stochastic Oscillator slumps into oversold zone

The Stochastic Oscillator for PRAA moved into oversold territory on November 09, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +2.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRAA advanced for three days, in 200 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

PRAA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRAA as a result. In 62 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for PRAA turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 35 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

PRAA moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PRAA crossed bearishly below the 50-day moving average on November 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRAA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.465) is normal, around the industry mean (3.902). P/E Ratio (-1.925) is within average values for comparable stocks, (6.401). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.918). Dividend Yield (0.103) settles around the average of (0.189) among similar stocks. P/S Ratio (0.577) is also within normal values, averaging (5.901).

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. PRAA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

Notable companies

The most notable companies in this group are VISA (NYSE:V), Mastercard (NYSE:MA), American Express Company (NYSE:AXP), Capital One Financial (NYSE:COF), PayPal Holdings (NASDAQ:PYPL), Synchrony Financial (NYSE:SYF), Bread Financial Holdings (NYSE:BFH), SLM Corp (NASDAQ:SLM), LexinFintech Holdings Ltd (NASDAQ:LX).

Industry description

A savings bank primary function is to take deposits and paying interest on those deposits. Originating in Europe during the 18th century, these banks were generally introduced to incentivize people of all stripes to save money and park them with banks. By the 1990s, the internet ushered in online savings banks that allowed savers to deposit/transact with banks digitally, without requiring to visit a branch office. Savings banks have potentially encouraged lower-income population to save and have access to a financial institution to earn interest on their money. New York Community Bancorp, Inc, Webster Financial Corporation, Washington Federal, Inc. are examples of savings banks.

Market Cap

The average market capitalization across the Savings Banks Industry is 36.75B. The market cap for tickers in the group ranges from 831.64K to 793.46B. V holds the highest valuation in this group at 793.46B. The lowest valued company is DXF at 831.64K.

High and low price notable news

The average weekly price growth across all stocks in the Savings Banks Industry was -3%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -12%. SEZL experienced the highest price growth at 18%, while PRAA experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Savings Banks Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 59
Price Growth Rating: 60
SMR Rating: 46
Profit Risk Rating: 79
Seasonality Score: 20 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the purchase, collection and management of portfolios of defaulted consumer receivables

Industry SavingsBanks

Industry
Miscellaneous Commercial Services
Address
120 Corporate Boulevard
Phone
+1 888 772-7326
Employees
2615
Web
https://www.pragroup.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.
CCAP climbed +7.03% during regular market hours, rising from a prior close of $9.24 to $9.89. The rally followed its Q3 2026 report: net investment income of $0.37/share beat the $0.35 consensus and revenue of $36.9M topped estimates, alongside a new $50M buyback authorization plus up to $25M in additional Sun Life purchases.